Home » Stocks » CTXR

Citius Pharmaceuticals, Inc. (CTXR)

Stock Price: $2.17 USD -0.01 (-0.46%)
Updated May 7, 2021 4:00 PM EDT - Market closed
After-hours: $2.11 -0.06 (-2.77%) May 7, 7:56 PM
Market Cap 292.30M
Revenue (ttm) n/a
Net Income (ttm) -21.37M
Shares Out 55.58M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE 1.29
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $2.17
Previous Close $2.18
Change ($) -0.01
Change (%) -0.46%
Day's Open 2.18
Day's Range 2.10 - 2.25
Day's Volume 4,284,806
52-Week Range 0.77 - 2.90

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Best penny stocks to watch in 2021? Here are 3 for your long term watchlist The post Trending Penny Stocks To Watch in 2021?

Other stocks mentioned: OGEN, SB
3 days ago - PennyStocks

We're diving back into the world of penny stocks again today as we look at those that are getting the most discussion over on Reddit. The post 5 Reddit Penny Stocks Seeing the Most Chatter Tuesday appea...

Other stocks mentioned: FAMI, PRPO, ZKIN, ZOM
3 days ago - InvestorPlace

Investors can seem to get enough of Reddit penny stocks news and we're looking at the most talked-about ones for Thursday. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thursday appeared first ...

Other stocks mentioned: ATOS, FAMI, PDAC, XXII
1 week ago - InvestorPlace

Penny stocks present opportunities to buy the dip often; is that the case with these biotech stocks? The post Hot Penny Stocks to Watch; Is it Time to Buy The Biotech Dip?

Other stocks mentioned: ATOS, VTGN
1 week ago - PennyStocks

CRANFORD, N.J., April 29, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company dedicated to the development and commercializat...

1 week ago - PRNewsWire

Reddit penny stocks are still all the rage from investors that aren't afraid of risks and we're taking a look at the most talked about today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Tuesd...

Other stocks mentioned: BB, GSAT, MVIS, ZOM
1 week ago - InvestorPlace

CRANFORD, N.J., April 22, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company dedicated to the development and commercializat...

2 weeks ago - PRNewsWire

Reddit penny stocks continue to be a hot topic among investors looking to take out investments in companies without having to break the bank. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thurs...

Other stocks mentioned: SENS, ZKIN, ZOM, BOIL
2 weeks ago - InvestorPlace

So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm.

Other stocks mentioned: ATNF, JAGX, OCGN, SVRA, TMBR, ZSAN
3 weeks ago - InvestorPlace

Yes, these Reddit penny stocks are all reasonably risky plays. But there is growth potential in each of these companies.

Other stocks mentioned: AREC, BB, BK, CIDM, CRON, RIOT, ULTA ...
3 weeks ago - InvestorPlace

Reddit penny stocks continue to be a hot subject among retail investors and we're looking at the most-talked-about ones today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Friday appeared firs...

Other stocks mentioned: ATNF, CGC, CTRM, ZOM
4 weeks ago - InvestorPlace

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Executive Chairman Leonard Mazur told Benzinga CEO Jason Raznick Thursday that he's invested $26.5 million of his own money in the specialty pharmaceutical com...

4 weeks ago - Benzinga

It's a great time to hold CTXR stock as the company's CEO shares his vision of significant corporate developments and clinical progress. The post Capital Raises and Clinical Programs Prove the Progress ...

1 month ago - InvestorPlace

Reddit penny stocks continue to be of interest to risky investors and InvestorPlace is looking at the top ones for Monday. The post 10 Reddit Penny Stocks Seeing the Most Chatter Today appeared first on...

Other stocks mentioned: AYTU, BNGO, DNN, HOFV, IDEX, MRKR, NEOS ...
1 month ago - InvestorPlace

Retail investors over on Reddit Penny Stocks are showing interest in quite a few interesting players today that investors will want to note. The post 7 Reddit Penny Stocks Seeing the Most Chatter Today ...

Other stocks mentioned: ATNF, MARA, SNDL, SVRA, TXMD, ZOM
1 month ago - InvestorPlace

CRANFORD, N.J., March 4, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care dru...

2 months ago - PRNewsWire

CRANFORD, N.J., Feb. 19, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a specialty pharmaceutical company focused on developing and commercializing critic...

2 months ago - PRNewsWire

Citius Pharmaceuticals (CTXR) stock is on the rise Friday with heavy trading of its shares despite a lack of news about the company today. The post CTXR Stock: 9 Things to Know About the Biotech Citius ...

2 months ago - InvestorPlace

CRANFORD, N.J., Feb. 17, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a specialty pharmaceutical company focused on developing and commercializing critic...

2 months ago - PRNewsWire

CRANFORD, N.J., Feb. 16, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care dru...

2 months ago - PRNewsWire

CRANFORD, N.J., Feb. 2, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug...

3 months ago - PRNewsWire

CRANFORD, N.J., Jan. 27, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critic...

3 months ago - PRNewsWire

CRANFORD, N.J., Dec. 15, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critic...

4 months ago - PRNewsWire

CRANFORD, N.J., Dec. 9, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critica...

4 months ago - PRNewsWire

CRANFORD, N.J., Nov. 30, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critic...

5 months ago - PRNewsWire

CRANFORD, N.J., Nov. 9, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug...

5 months ago - PRNewsWire

Citius Pharmaceuticals: Phase 3 Catalyst Countdown And Ready For Take Off

6 months ago - Seeking Alpha

CRANFORD, N.J., Oct. 7, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug...

7 months ago - PRNewsWire

CRANFORD, N.J., Sept. 30, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing criti...

7 months ago - PRNewsWire

CRANFORD, N.J., Sept. 29, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing criti...

7 months ago - PRNewsWire

CRANFORD, N.J., Sept. 22, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing criti...

7 months ago - PRNewsWire

CRANFORD, N.J., Sept. 15, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

7 months ago - PRNewsWire

CRANFORD, N.J., Sept. 8, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

7 months ago - PRNewsWire

CRANFORD, N.J., Aug. 26, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

8 months ago - PRNewsWire

CRANFORD, N.J., Aug. 13, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

8 months ago - PRNewsWire

CRANFORD, N.J., Aug. 10, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

8 months ago - PRNewsWire

CRANFORD, N.J., Aug. 5, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

9 months ago - PRNewsWire

CRANFORD, N.J., Aug. 5, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

9 months ago - PRNewsWire

CRANFORD, N.J., Aug. 4, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

9 months ago - PRNewsWire

CRANFORD, N.J., July 22, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

9 months ago - PRNewsWire

CRANFORD, N.J., July 20, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc.

9 months ago - PRNewsWire

CRANFORD, N.J., July 14, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critic...

9 months ago - PRNewsWire

CRANFORD, N.J., July 13, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical c...

9 months ago - PRNewsWire

Citius Pharmaceuticals (CTXR) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

10 months ago - Zacks Investment Research

CRANFORD, N.J., June 29, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critic...

10 months ago - PRNewsWire

CRANFORD, N.J., June 26, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critic...

10 months ago - PRNewsWire

CRANFORD, N.J., June 22, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critic...

10 months ago - PRNewsWire

CRANFORD, N.J., June 2, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critica...

11 months ago - PRNewsWire

CRANFORD, N.J., May 26, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critica...

11 months ago - PRNewsWire

CRANFORD, N.J., May 18, 2020 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today annou...

11 months ago - PRNewsWire

About CTXR

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. The company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase III clinical trials; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast rec... [Read more...]

Industry
Biotechnology
Founded
2007
CEO
Myron Holubiak
Employees
10
Stock Exchange
NASDAQ
Ticker Symbol
CTXR
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for CTXR stock is "Buy" and the 12-month stock price forecast is 6.00.

Price Target
$6.00
Analyst Consensus: Buy